FDA panel votes unanimously in favor of authorizing J&J vaccine

A sign at the Johnson & Johnson campus on August 26, 2019 in Irvine, California.

Enlarge / An indication on the Johnson & Johnson campus on August 26, 2019 in Irvine, California. (credit score: Getty | Mario Tama)

After a day-long assembly Friday, an advisory panel for the US Meals and Drug Administration voted 22 to zero to advocate issuing an Emergency Use Authorization for Johnson & Johnson’s single-shot, refrigerator-stable COVID-19 vaccine.

If the FDA accepts the panel’s advice and grants the EUA—which it probably will—the nation could have a 3rd COVID-19 vaccine approved to be used. Earlier this week, FDA scientists launched their evaluation of the vaccine, endorsing authorization. In the present day’s panel, the FDA’s Vaccines and Associated Organic Merchandise Advisory Committee (VRBPAC) went by means of the info additional.

“It’s a comparatively straightforward name,” Eric Rubin, a Harvard researcher and voting member of the VRBPAC mentioned after the vote. “[The vaccine] clearly will get approach over the bar and it’s good to have a single-dose vaccine… the demand is so giant [for vaccines], it clearly has a spot.”

Learn 9 remaining paragraphs | Feedback

Related Posts

Leave a Reply

Your email address will not be published.